518 related articles for article (PubMed ID: 18830669)
81. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
[TBL] [Abstract][Full Text] [Related]
82. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
[TBL] [Abstract][Full Text] [Related]
83. Minimally invasive esophagectomy for stage I and II esophageal cancer.
Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T
Ann Thorac Surg; 2005 Dec; 80(6):2070-5. PubMed ID: 16305846
[TBL] [Abstract][Full Text] [Related]
84. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone.
Kesler KA; Helft PR; Werner EA; Jain NP; Brooks JA; DeWitt JM; Leblanc JK; Fineberg NS; Einhorn LH; Brown JW
Ann Thorac Surg; 2005 Apr; 79(4):1116-21. PubMed ID: 15797035
[TBL] [Abstract][Full Text] [Related]
85. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Akutsu Y; Hayashi H; Isono K; Ochiai T
J Am Coll Surg; 2008 Jan; 206(1):48-56. PubMed ID: 18155568
[TBL] [Abstract][Full Text] [Related]
86. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
[TBL] [Abstract][Full Text] [Related]
87. Pathological determinants of survival in node-negative oesophageal cancer.
Khan OA; Alexiou C; Soomro I; Duffy JP; Morgan WE; Beggs FD
Br J Surg; 2004 Dec; 91(12):1586-91. PubMed ID: 15505868
[TBL] [Abstract][Full Text] [Related]
88. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
89. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram.
Lagarde SM; Reitsma JB; Maris AK; van Berge Henegouwen MI; Busch OR; Obertop H; Zwinderman AH; van Lanschot JJ
Ann Thorac Surg; 2008 Jun; 85(6):1938-45. PubMed ID: 18498798
[TBL] [Abstract][Full Text] [Related]
90. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
[TBL] [Abstract][Full Text] [Related]
91. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
[TBL] [Abstract][Full Text] [Related]
92. Outcome following surgery for squamous cell carcinoma of the oesophagus.
Yong EL; Han XP; Watson DI; Devitt PG; Jamieson GG; Thompson SK
ANZ J Surg; 2009 Oct; 79(10):724-8. PubMed ID: 19878168
[TBL] [Abstract][Full Text] [Related]
93. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
94. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
[TBL] [Abstract][Full Text] [Related]
95. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
96. [Esophageal carcinoma: guidelines in surgical therapy].
Kremer B; Marxsen J; Grimm H; Stoffregen C; Schmid A; Henne-Bruns D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():284-9. PubMed ID: 9931626
[TBL] [Abstract][Full Text] [Related]
97. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.
Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185
[TBL] [Abstract][Full Text] [Related]
98. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
99. Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Yang JS; Yang WP; Liu DT; Chen YP; Zhang H
J Thorac Oncol; 2013 Apr; 8(4):495-501. PubMed ID: 23446203
[TBL] [Abstract][Full Text] [Related]
100. Outcomes after oesophagogastrectomy for carcinoma of the oesophagus.
Omundsen M; Babor R; Johnston P
ANZ J Surg; 2007; 77(1-2):37-9. PubMed ID: 17295818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]